![Andrew Cheng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 621 174 $ al 31/05/2026
Andrew Cheng is currently an Independent Director at Vera Therapeutics, Inc. since 2017 and a Director at Boys & Girls Clubs of Metro Los Angeles.
Formerly, Dr. Cheng was President, Chief Executive Officer & Director at Akero Therapeutics, Inc. from 2018 to 2025; Independent Director at Arbutus Biopharma Corp.
from 2019 to 2022; Director at Syntimmune, Inc.; Director at Global Virus Network; Non-Executive Director at MorphoSys AG from 2022 to 2024; and Chief Medical Officer & Executive Vice President at Gilead Sciences, Inc. in 2018.
Education includes an undergraduate degree from The Johns Hopkins University in 1988 and a doctorate from Columbia University College of Physicians & Surgeons in 1996.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/05/2026 | 17.488 ( 0,02 % ) | 621 174 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VERA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/05/2017 |
Boys & Girls Clubs of Metro Los Angeles
 Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| AKERO THERAPEUTICS, INC. | Director Ejecutivo | 09/12/2025 |
| MORPHOSYS AG | Director/Miembro de la Junta | 06/06/2024 |
| ARBUTUS BIOPHARMA CORPORATION | Director/Miembro de la Junta | 25/05/2022 |
| GILEAD SCIENCES, INC. | Director Técnico/Científico/I+D | 07/09/2018 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Columbia University College of Physicians & Surgeons
 Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
Boys & Girls Clubs of Metro Los Angeles
Boys & Girls Clubs of Metro Los Angeles Miscellaneous Commercial ServicesCommercial Services Operates as a Non-profit organization that provides proven programming services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
